MobiHealthNews

Gemalto wirelessly enables TZ Medical's arrhythmia monitor

Gemalto-owned Cinterion has inked a deal with TZ Medical to embed a cellular wireless chip into the medical device company's heart arrhythmia monitoring device, Aera-CT, which the companies expect to ...
MobiHealthNews

AT&T provides eCardio with wireless connectivity for arrhythmia monitoring

AT&T has inked a deal with eCardio Diagnostics to provide wireless connectivity to the arrhythmia monitoring company's near real-time cardiac monitoring devices. eCardio’s monitoring devices enable ...
Hosted on MSN

IRhythm demonstrates value in 14-day monitoring for arrhythmia recurrence

New data from iRhythm Technologies has demonstrated that extending the cardiac monitoring duration for arrhythmia recurrence to 14 days resulted in a more complete clinical assessment in post-ablation ...
Nasdaq

Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device

REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced ...
Healio

FDA clears next-generation insertable device for long-term arrhythmia monitoring

Please provide your email address to receive an email when new articles are posted on . Boston Scientific announced the FDA clearance of its next-generation insertable cardiac monitor for long-term ...
MD&M East

How iRhythm Is Transforming Primary Care with AI & Wearable Tech

iRhythm Technologies has always had an interesting position in the medtech industry. The San Francisco-based company resides at the intersection of artificial intelligence, wearables, and cardiology.
The American Journal of Managed Care

Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients

Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer retests and cardiovascular events, and lower health ...
Medscape

Current and Emerging Indications for Implantable Cardiac Monitors

Implantable cardiac monitors (ICMs) continuously monitor the patient's electrocardiogram and perform real-time analysis of the heart rhythm, for up to 36 months. The current clinical use of ICMs ...
Seeking Alpha

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) ...
The American Journal of Managed Care

Wearable Devices Heighten Symptom Monitoring, Health Care Visits for Atrial Fibrillation

Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and increased health care usage than nonusers. Although there are concerns ...
Nasdaq

New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy

SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC) today announced results from two real-world retrospective analyses in post-ablation and pregnancy patient ...